RFP - developing and deploying advocacy strategies to promote COVID-19 diagnostic testing and linkage to care and treatment in LMICs
Organization: Foundation for Innovative New Diagnostics
Apply By: 02 Feb 2022
REQUEST FOR PROPOSAL (RFP) DEVELOPING AND DEPLOYING ADVOCACY STRATEGIES TO PROMOTE COVID-19 DIAGNOSTIC TESTING AND LINKAGE TO CARE AND TREATMENT IN LOW- AND MIDDLE INCOME COUNTRIES (LMICS)
FIND, the global alliance for diagnostics, seeks to ensure equitable access to reliable diagnosis around the world. We connect countries and communities, funders, decisionmakers, healthcare providers and developers to spur diagnostic innovation and make testing an integral part of sustainable, resilient health systems. We are working to save 1 million lives through accessible, quality diagnosis, and save US$1 billion in healthcare costs to patients and health systems. We are co-convener of the Access to COVID19 Tools (ACT) Accelerator diagnostics pillar, and a WHO Collaborating Centre for Laboratory Strengthening and Diagnostic Technology Evaluation. More about FIND and our programmes can be found on www.finddx.org.
Unitaid is a global health agency engaged in finding innovative solutions to prevent, diagnose, and treat diseases more quickly, cheaply, and effectively, in low- and middle-income countries. Its work includes funding initiatives to address major diseases such as HIV, malaria, and tuberculosis, as well as HIV coinfections and co-morbidities including advanced HIV disease, cervical cancer, and hepatitis C, and cross-cutting areas, such as fever management. Unitaid is now applying its expertise to address challenges in advancing new therapies and diagnostics for the COVID-19 pandemic, serving as a key member of the Access to COVID-19 Tools (ACT) Accelerator, co-leading with Wellcome the Therapeutics Pillar and participating in the Diagnostics Pillar. Unitaid is hosted by the World Health Organization. For more information, please visit www.unitaid.org
STATEMENT OF PURPOSE AND OBJECTIVES:
The overarching goal of this RFP is to create an enabling environment for increased access to and scaled-up use of COVID-19 testing and linkage to treatment in target regions (Africa, Asia, Latin America, Middle East).
Specific objectives are to:
- increase access and uptake to COVID-19 testing and therapeutics, as they get recommended, through development and implementation of robust and evidence-based advocacy strategies supported by advocacy, literacy and communication materials and initiatives adapted to specific population groups, regional and country contexts
- disseminate and amplify these materials and initiatives through appropriate communication channels to increase prioritization of COVID-19 testing and linkage to treatment in the national pandemic response as well as generate demand for testing and therapeutics within relevant target groups
FIND and Unitaid, through the ACT-Accelerator, are seeking the services of organizations with a proven record of advocacy and awareness-raising in healthcare in LMICs, to implement projects to achieve these objectives.
SCOPE OF WORK AND DELIVERABLES:
The scope of the RFP is restricted to national or regional health awareness raising and advocacy. The selected organizations would be expected to solicit and validate messaging in a bottom-up approach with country partners in target geographies.
Applicants are expected to consider advocacy approaches that will increase testing rates in line with UNGA testing targets (1 test/1000/day), and adequate linkage to treatment, in alignment with
recommendations in force, following diagnosis. Activities should be centred on developing advocacy strategies, literacy and messaging and media content for use in local contexts, as well as wider dissemination and amplification. Deliverables are to include:
- A multi-pronged advocacy strategy for increased testing and adequate linkage with treatment based on information gathered about local context, including challenges, opportunities, and target audiences.
- Tailored (and “pressure-tested”) messages on testing and diagnostics, as well as on therapeutics, for key target audiences, including media, key opinion leaders, policy makers, and healthcare workers, and public.
- Advocacy and educational materials, translated into local language and tailored to local contexts for both high-level advocacy and community outreach. To this end ACT-A partners in the Diagnostics Pillar and Therapeutics Pillar would provide relevant information as it becomes available to complement other sources.
- Dissemination and amplification of advocacy and educational materials via multiple channels appropriate for local/regional settings and target audiences (e.g., events, social media, radio, television, internet, newspaper, theatre, media training workshops etc.).
The development of materials (in English, French, Spanish, Portuguese, and other local languages as relevant) and dissemination approach is anticipated to include a diverse array of content relevant to the target stakeholder group as outlined in the proposal.
Material produced for dissemination should be freely accessible to use and not limited by intellectual property or copyright considerations.
HOW TO APPLY:
Applicants are limited to one proposal per organization for this RFP. Please submit your completed proposal document (as per the guidelines in Section 7) and send to [advocacy_RFP@finddx.org ] no later than 2 February 2022 at 17h00 CET. Any proposal received by
FIND after the closing date for submission may be rejected. All applicants are required to complete a self-check form, as seen in Appendix B.
For more information, please check the Link
Latest Online Store
© Renalysis Consultants Pvt Ltd